Top 5 Wireless Telecom Stocks To Watch For 2015

Top 5 Wireless Telecom Stocks To Watch For 2015: Intelsat SA (I)

Intelsat S.A., incorporated on July 18, 2011, is a satellite services business, providing a layer in the global communications infrastructure. The Company operates satellite capacity, holds orbital location rights, contract backlog, serve commercial customers and deliver services. It provides diversified communications services to the world's media companies, fixed and wireless telecommunications operators, data networking service providers for enterprise and mobile applications, multinational corporations and Internet service providers (ISPs). It is also the provider of commercial satellite capacity to the United States government and other select military organizations and their contractors.

The Company has a satellite fleet comprised of more than 50 satellites, covering 99% of the Earth's populated regions. Its fleet, combined with the IntelsatOne terrestrial fiber network and a collection of teleports, form a singular unmatched global infrastructure t o meet any communications requirement. As the provider of satellite services, the Company provides mission critical communication services.

Advisors' Opinion:

• [By Todd Sullivan]

  HHC has increased all our ownership percentage through the repurchasing of outstanding warrants.

  From the 13D/A
  On December 31, 2013, certain of the Reporting Persons entered into swaps for the benefit of certain Pershing Square Funds. Under the terms of the swaps, (i) the relevant Pershing Square Funds will be obligated to pay to the bank counterparty any negative price performance of the 5,399,839 notional number of Common Shares subject to the swaps as of the expiration date of such swaps, plus interest rates set forth in the applicable contracts, and (ii) the bank counterparty will be obligated to pay the relevant Pershing Square Funds any positive ! price performance of the 5,399,839 notional number Common Shares subject to the swaps as of the expiration date of the swaps. During the term of the swaps, cash will be paid by the bank counterparty to the relevant Pershing Square Fund in an amount equal to the amount of notional distributions or dividends paid by the Issuer in respect of such notional number of Common Shares. All balances will be settled in cash. The Pershing Square Funds' counterparties for the swaps include entities related to Citibank, Nomura, Société Générale and UBS. The swaps do not give the Reporting Persons direct or indirect voting, investment or dispositive control over any securities of the Issuer and do not require the counterparty thereto to acquire, hold, vote or dispose of any securities of the Issuer. Accordingly, the Reporting Persons disclaim any beneficial ownership of any Common Shares that may be referenced in the swap contracts or Common Shares or other securities or financial instruments that may be held from time to time by any counterparty to the contracts.

• [By Rich Duprey]

  Satellite services provider Intelsat (NYSE: I  ) announced yesterday its third-quarter dividend of $0.71875 per share on its 5.75% Series A mandatory convertible junior non-voting preferred stock, which trades on the NYSE under the symbol I.PRA.

source from Top Stocks For 2015:http://www.topstocksblog.com/top-5-wireless-telecom-stocks-to-watch-for-2015.html

Hot High Tech Stocks To Own For 2014

Although business headlines still tout earnings numbers, many investors have moved past net earnings as a measure of a company's economic output. That's because earnings are very often less trustworthy than cash flow, since earnings are more open to manipulation based on dubious judgment calls.

Earnings' unreliability is one of the reasons Foolish investors often flip straight past the income statement to check the cash flow statement. In general, by taking a close look at the cash moving in and out of the business, you can better understand whether the last batch of earnings brought money into the company, or merely disguised a cash gusher with a pretty headline.

Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on PVH (NYSE: PVH  ) , whose recent revenue and earnings are plotted below.

Top 10 High Dividend Companies To Buy For 2015: Lenovo Group Ltd (LNVGF.PK)

Lenovo Group Limited is principally engaged in investment holding. It is a personal technology company serving customers in more than 160 countries. The Company is a personal computer (PC) vendor. The Company develops, manufactures and markets technology products and services. Its product lines include Think-branded commercial PCs and Idea branded consumer PCs, as well as servers, workstations, and a family of mobile Internet devices, including tablets and smart phones. It offers a range of commercial desktops and notebooks to businesses of all sizes that feature cutting-edge technology, customer-centric innovation and productivity features. It operates in three segments: China, Emerging Markets (excluding China) and Mature Markets. Lenovo has research centers in Yamato, Japan; Beijing, Shanghai and Shenzhen, China; and Raleigh, North Carolina, the United States. Advisors' Opinion:

• [By Investometrica]

  x86: With regards to the specific x86 server business, it seems that IBM is considering the possibility of fully divesting it. According to Morgan Stanley, the server business generated about $4.9 billion of the company's $15.4 billion in server sales last year. This enormous volume is due to the fact that IBM may be producing the overall market's highest volumes, at the lowest profit level; which suggests this segment is doomed. Finally, IBM has a history of aggressive shifts to areas with better growth prospects and margins. For example, the company agreed to sell off the PC business to Lenovo (LNVGF.PK) at a moment where the PC still seemed attractive.

Hot High Tech Stocks To Own For 2014: Copart Inc. (CPRT)

Copart, Inc. provides online auctions and vehicle remarketing services in the United States, Canada, and the United Kingdom. The company offers a range of services for processing and selling vehicles over the Internet through its Virtual Bidding Second Generation Internet auction-style sales technology, to vehicle sellers, primarily insurance companies, banks and financial institutions, charities, car dealerships, fleet operators, and vehicle rental companies. Its services include online seller access, salvage estimation services, estimating services, end-of-life vehicle processing, virtual insured exchange, transportation services, vehicle inspection stations, on-demand reporting, DMV processing, flexible vehicle processing programs, member network, sales process, dealer services, direct services, and u-pull-it services, as well as CoPartfinder, an Internet-based used vehicle parts locator that provides vehicle dismantlers with resale opportunities for their purchases. Th e company sells its products to licensed vehicle dismantlers, rebuilders, repair licensees, used vehicle dealers, and exporters, as well as the general public. Copart, Inc. was founded in 1982 and is headquartered in Fairfield, California.

Advisors' Opinion:

• [By Geoff Gannon] s thousands of acres of land around the U.S. Some of it is quite valuable. It�� carried on the balance sheet at $343 million. That number excludes buildings and improvements (which had an original cost of another $384 million).

  Some of that land ��for example, some of the earliest properties they still own in California ��are worth much, much more than they are carried for.

  But that fact actually isn�� that important. Why not?

  Because Copart earns very high returns on its net tangible assets. We��e talking about probably 20% to 30% returns on tangible investment. You don�� normally earn 20% on land. So, the value of land is not very high outside of Copart�� operations relative to what it is worth inside Copart�� operations.

  And, yes, the land is critical to Copart�� operations. They don�� necessarily have to own it ��a major competitor leases almost all of its land ��but they do have to control it.

  Now, if something were ever to happen to Copart�� business where you had a long-term deterioration in the car salvage business that land might become very important to an analysis of Copart.

  Let�� assume that tomorrow there is some high tech crash avoidance system. For example, cars are navigated remotely rather than being driven by someone inside the car.

  Under those circumstances, Copart�� business would be forever changed. The volume of wrecks would decline. And Copart�� invested assets ��like its big salvage yards ��would become much less valuable inside Copart�� business.

  That means the market value of the land would now be a lot higher relative to the value Copart could get from using the land to store cars. This would change the analysis entirely. And suddenly Copart�� balance sheet would be worth careful analysis.

  While this sounds farfetched, it�� actually the kind of thing that happens at net-nets and other stocks that are valuable on a liquidation basis. They start

• [By Geoff Gannon]

  The same rule applies here that I mentioned with Copart (CPRT) in an earlier article. Although Wal-Mart is an inferior business to Copart from a pure ROI standpoint, it�� still earning good returns on its investment.

Hot High Tech Stocks To Own For 2014: Campus Crest Communities Inc (CCG)

Campus Crest Communities, Inc., incorporated on March 1, 2010, is a self-managed, self-administered and vertically-integrated developer, builder, owner and manager of purpose-built student housing properties in the United States. The Company operates in two segments: student housing operations and development, construction and management services. It owns the general partner interest and owns limited partner interests in Campus Crest Communities Operating Partnership, LP (the Operating Partnership). It holds substantially all of its assets and conducts substantially all of its business, through the Operating Partnership. As of December 31, 2010, it owned interests in 27 operating student housing properties containing approximately 5,048 apartment units and 13,580 beds. Twenty-one of its properties, containing approximately 3,920 apartment units and 10,528 beds, are wholly owned. On October 19, 2010, it acquired the remaining interest in Campus Crest at San Marcos, LLC, which owns The Grove at San Marcos, from HSRE. In January 2012, the Company acquired 50.1% interests in The Grove. On December 27, 2013, the Company closed its sale of four wholly owned student housing properties. In January 2014, Campus Crest Communities Inc and Beaumont Partners joint venture partnership acquired the 488-room, 22-story Holiday Inn Midtown in Montreal, Quebec.

As of December 31, 2010, the average occupancy for its 27 properties was approximately 88%. Its properties are primarily located in medium-sized college and university markets. As of December 31, 2010, the Company were party to one joint venture arrangement with HSRE, in which it owns a 49.9% interest.

Student Housing Operations

The Company�� student housing operations are consisted of rental and other service revenues, such as application fees, pet fees and late payment fees. In August 2010, the Company opened three additional properties that were owned by the same real estate venture.

Development, Construc! tion and Management Services

The Company provides development and construction services to unconsolidated joint ventures in which it has an ownership interest. The Company acts as a general contractor on all of its construction projects. In addition to its wholly owned properties, all of which are managed by the Company, it also provides management services to uncombined joint ventures in which, it has an ownership interest.

Advisors' Opinion:

• [By Jonas Elmerraji]

  2013 is panning out to be a rough year for Campus Crest Communities (CCG) -- shares of the small-cap student housing REIT have slid 12.7% since the calendar flipped over to January. While that sounds bad enough as it is, it's actually 31% underperformance vs. the S&P 500. And a quick glance at the chart makes it pretty clear to see why.

  CCG is stuck in a textbook downtrend right now, bouncing between trendline resisatnce to the upside and a parallel support level below. You don't have to be an expert technical analyst to figure out where CCG's high probability price action is from here; it's down. Trendline resistance has acted as a ceiling for shares on the last four tests in 2013 – and with shares hitting their head on that resistance level this week, now's the optimal time to sell (or short) this REIT.

  If you're looking for an opportunity to buy CCG, you could be in for a long wait. But the 50-day moving average has been a pretty good proxy for resistance since the start of the summer. I'd recommend waiting for that line to get broken before even thinking about doing anything but selling this stock. Until then, it's toxic.

Hot High Tech Stocks To Own For 2014: Discovery Laboratories Inc.(DSCO)

Discovery Laboratories, Inc., a biotechnology company, focuses on developing products for the treatment of respiratory disease. The company?s product pipeline includes Surfaxin, a synthetic, peptide-containing surfactant that has completed Phase-III pivotal trial for the prevention of respiratory distress syndrome (RDS) in premature infants; Surfaxin LS, a lyophilized dosage form of Surfaxin in Phase-III clinical trials, which enhances ease of use for healthcare practitioners; and AEROSURF, a drug-device combination product that has completed first pilot Phase II clinical study of aerosolized KL4 surfactant for the prevention of RDS in premature infants. It has license agreements with Philip Morris USA Inc.; Philip Morris Products S.A.; Johnson & Johnson; and Ortho Pharmaceutical Corporation for its capillary aerosolization and KL4 surfactant technologies. The company also has a strategic alliance with Laboratorios del Dr. Esteve, S.A. for the development, marketing, and sale of a portfolio of potential KL4 surfactant products in Andorra, Greece, Italy, Portugal, and Spain. Discovery Laboratories, Inc. was founded in 1992 and is headquartered in Warrington, Pennsylvania.

Advisors' Opinion:

• [By Eric Volkman]

  Discovery Laboratories (NASDAQ: DSCO  ) is turning its focus to raising capital. The company will float 9.5 million shares of its common stock in an underwritten public offering. The price is $1.50 per share. Additionally, its underwriter has been granted a 30-day purchase option for up to an additional 1.425 million shares to cover overallotments, if any.

• [By Sue Chang and William L. Watts]

  Shares of Discovery Laboratories Inc. (DSCO) �surged 39%. The company said the Food and Drug Administration had agreed to the company�� updated product specifications for its Surfaxin intratracheal suspension, which was approved for the prevention of respiratory distress in prematurely born infants.

• [By Paul Ausick]

  Stocks on the Move: Potbelly Corp. (NASDAQ: PBPB) is up 119.1% at $30.68 after a blistering IPO at $14 a share. OCI Partners LP (NYSE: OCIP) is up 5.6% at $19.01 after an IPO at $18.00 a share. Cherry Hill Mortgage Investment Corp. (NYSE: CHMI) is down 7.6% at $18.48 following its IPO on Friday morning. Discovery Laboratories Inc. (NASDAQ: DSCO) is up 37.1% at $2.70 following approval of updated specifications for a drug to prevent respiratory distress in premature infants. Forest Oil Corp. (NYSE: FST) is down 9.7% at $5.74 following the sale of $1 billion worth of assets in the Texas panhandle.

• [By David Williamson]

  In this video, Fool health-care analyst David Williamson discusses Discovery Labs (NASDAQ: DSCO  ) , as it struggles with yet another delay to its drug Surfaxin. Shares are down 15% on news that the FDA has requested Surfaxin product specifications and a new analytical chemistry method. It took the company an unbelievable five attempts to finally get this drug approved a year ago. David tells investors when they might expect the delays to end, and what the key things to watch with Discovery Labs will be in the meantime, as the company continues to lose out on sales and burn cash.

Hot High Tech Stocks To Own For 2014: Stone Energy Corporation(SGY)

Stone Energy Corporation, an independent oil and natural gas company, engages in the acquisition, exploration, exploitation, development, and operation of oil and gas properties in the Gulf of Mexico and the Appalachia region. As of December 31, 2010, it had estimated proved oil and natural gas reserves of approximately 473.9 billion cubic feet of gas equivalent. The company was founded in 1993 and is headquartered in Lafayette, Louisiana with additional offices in New Orleans, Louisiana; Houston, Texas; and Morgantown, West Virginia.

Advisors' Opinion:

• [By John Udovich]

  While the Bakken formation is already on most investor radars,�few American investors may realize that the formation stretches North into the oil and gas rich Canadian province of Saskatchewan where�stocks like Surge Energy Inc (TSE: SGY), Questerre Energy Corp (TSE: QEC), Crescent Point Energy Corp (TSE: CPG), Keyera Corp (TSE: KEY) and Centor Energy Inc (OTCBB: CNTO) have been pumping out a good flow of newsworthy news in recent weeks. I should mention that Canada�� oil reserves are ranked #3 after to Venezuela and Saudi Arabia with over 95% of these reserves being the oil sands of Alberta while the neighboring province of Saskatchewan (which the Bakken formation stretches into from South Dakota and Montana) along with offshore areas of Newfoundland also contain substantial production and reserves (Note:�Excluding oil sands, Alberta would have 39% of Canada�� remaining conventional oil reserves,�followed by�offshore Newfoundland with�28% and Saskatchewan with 27%).

Best Biotech Companies To Own For 2014

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of Insmed (NASDAQ: INSM  ) , a clinical-stage biotechnology company focused on inhaled therapies for diseases of the lung, jumped as much as 18% after a pair of brokerage firms boosted their price targets on the company.

So what: Just hours apart from one another, Canaccord Genuity boosted its price target on Insmed from $12 to $17 while Leerink Swann raised its target all the way to $22 from $13. The impetus behind both price target hikes was similar: an expected approval of Arikace, the company's inhaled first-line treatment for non-tuberculosis mycobacterial infections. These two price target bumps come one week after Lazard�Capital Management raised its price target on Insmed to $21 and the covering analyst, Joshua Schimmer, projecting sales of $600 million annually by 2020.

Hot Communications Equipment Companies For 2015: InterMune Inc.(ITMN)

InterMune, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of therapies in pulmonology and fibrotic diseases. In pulmonology, the company focuses on therapies for the treatment of idiopathic pulmonary fibrosis (IPF), a progressive and fatal lung disease. It markets pirfenidone, an orally active drug that inhibits the synthesis of TGF-beta under the Esbriet name in the European Union, as well as in a Phase III clinical trial in the United States. Pirfenidone is also approved for the treatment of IPF in Japan, where it is marketed by Shionogi & Co. Ltd. under the Pirespa trade name. The company?s research programs focus on the discovery of small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. InterMune, Inc. was founded in 1998 and is headquartered in Brisbane, California.

Advisors' Opinion:

• [By Ben Levisohn]

  InterMune (ITMN) has ticked up 0.2% despite being downgraded by JPMorgan and JMP Securities.

  DSW (DSW) had jumped 12% to $31.90 after the shoe retailer beat earnings forecasts and raised its guidance.

Best Biotech Companies To Own For 2014: Gentium SpA(GENT)

Gentium S.p.A., a biopharmaceutical company, focuses on the development and manufacture of its primary product candidate, defibrotide, an investigational drug based on a mixture of single-stranded and double-stranded DNA extracted from pig intestines. It develops defibrotide for the treatment and prevention of hepatic veno-occlusive disease (VOD), a condition that occurs when veins in the liver are blocked as a result of cancer treatments, such as chemotherapy or radiation, that are administered prior to stem cell transplantation. The company has completed a Phase III clinical trial of defibrotide for the treatment of severe VOD in the United States, Canada, and Israel; and a Phase II/III pediatric trial in Europe for the prevention of VOD. It also offers sulglicotide that is developed from swine duodenum, and has ulcer healing and gastrointestinal protective properties in South Korea; and urokinase, which is made from human urine to treat various vascular disorders, such as deep vein thrombosis and pulmonary embolisms. The company was formerly known as Pharma Research S.r.L. and changed its name to Gentium S.p.A. in July 2001. Gentium S.p.A. was founded in 1993 and is headquartered in Villa Guardia, Italy.

Advisors' Opinion:

• [By James Oberweis]

  Gentium Spa (GENT) is focused on the development and commercialization of its leading product, defibrotide, to treat certain complications arising from chemotherapy, and bone marrow and stem cell transplantation therapy.

• [By Sean Williams]

  A parabolic problem
  It has also been a year to remember for shareholders of biopharmaceutical company Gentium (NASDAQ: GENT  ) whose share price has catapulted approximately 600% off its lows thanks to growth in its lead drug Defibrotide (known as Defitelio in the European Union).

• [By Jake L'Ecuyer]

  Shares of Jazz Pharmaceuticals Public Limited Company (NASDAQ: JAZZ) got a boost, shooting up 7.77 percent to $123.65 after the company announced its plans to buy Gentium SpA (NASDAQ: GENT) for around $1 billion.

Best Biotech Companies To Own For 2014: DiaMedica Inc (DMA)

DiaMedica Inc. (DiaMedica) is a development-stage company. The Company is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of diabetes and related diseases. DiaMedica's compound, DM-199, is a recombinant human protein for the treatment of both Type I and Type II diabetes and their complications. DiaMedica is starting a Phase I/II clinical trial for DM-199. DM-199 is a recombinant human protein, which improves glucose control, protects beta cells through the expansion of a population of antigen-specific immunosuppressive cells (Tregs), and proliferates insulin producing beta cells through the activation of certain growth factors. The Company�� DM-204 is a G-protein-coupled receptor agonist (GPCR) monoclonal antibody to treat Type II diabetes and some of the associated complication's. activating a receptor resulted in insulin sensitivity, insulin secretion and vasodilation. Advisors' Opinion:

• [By Richard Rhodes]

  Given this economic backdrop, and developing pressure on corporate revenues, margins, and earnings, we feel that risk is being misplaced at current levels.

  The 14-day and 40-day models are now overbought. Now, the 14-day and 40-day are peaking, which would certainly indicate a correction stands as the highest probability.
  
  The % of stocks above their 10-day moving average (dma) is at the 70%-level; still a major divergence with prices.
  
  The % of stocks above their 200-dma stands at 77%. The 87% level marked previous highs. The 50-dma/150-dma cross breakdown now confirms a larger correction. Bottoms form between 30%-40%.
  
  Overall, the risk-reward remains skewed to the downside, regardless of whether prices remain above trendline resistance, as our model group suggests a correction to the 110-day moving average, currently at S&P 1711.
  
  

  A clear breakdown at that level would accelerate the decline towards the wide 200-dma and 380-dma range, between 1657-1571.

Best Biotech Companies To Own For 2014: Actelion Ltd (ATLN.VX)

Actelion Ltd is a Swiss biopharmaceutical holding company that focuses on the discovery, development and commercialization of small molecule drugs. The Company has four approved drugs on the market: Tracleer, an oral dual endothelin receptor antagonist; Veletri, a prostanoid vasodilator; Ventavis, an inhaled formulation of iloprost, and Zavesca, an oral treatment for type 1 Gaucher disease. Furthermore, the Company has a number of compounds various stages of development. The Company operates through a number of worldwide subsidiaries, including Actelion Registration Ltd, which holds marketing authorizations for products marketed in the European Union; Actelion Clinical Research, Inc, engaged in clinical development on behalf of the Company's group; Actelion Re SA, providing insurance solutions for the Company's group and Actelion US Holding Company, engaged in the holding activities of the Company's United States-based units. In September 2013, it acquired Ceptaris Therapeutics, Inc. Advisors' Opinion:

• [By Victor Selva]

  Forest Laboratories has a current ratio of 2.69% which is higher than the ones registered by Endo International Plc (ENDP), Valeant Pharmaceuticals International (VRX) and Cubist Pharmaceuticals Inc. (CBST). For investors looking for a higher ROE, Allergan Inc. (AGN) and Actelion Ltd. (ATLN.VX) are good options.

Best Biotech Companies To Own For 2014: Prothena Corporation PLC (PRTA)

Prothena Corporation PLC, incorporated on September 26, 2012, is an Ireland-based, clinical-stage biotechnology company. The Company is engaged in discovering and developing monoclonal antibodies that are directed towards misfolded proteins or improper cell adhesion. Its pipeline includes NEOD001, PRX002 and PRX003. The Company�� work in protein misfolding could result in therapies to treat several neurodegenerative diseases, including AL (primary) and AA (secondary) forms of amyloidosis (NEOD001), Parkinson's disease and related synucleinopathies (PRX002). Its cell adhesion development activities could generate new therapies to treat inflammatory diseases and metastatic cancers (PRX003). The Company�� program, NEOD001, is in Phase 1. In addition to antibodies directed to neo-epitope targets, it is developing antibodies directed to other targets. The Company has generated antibodies against cell adhesion targets expressed on certain pathogenic Th17 immune cells and tumor cells.

The Company�� pipeline also includes several late discovery stage programs for which it is testing antibodies in preclinical models of disease. It is also generating additional antibodies against other targets involved in protein misfolding and cell adhesion for characterization in vivo and in vitro.

NEOD001 for Amyloidosis

NEOD001 is a monoclonal antibody that targets the amyloid that accumulates in both AL and AA forms of amyloidosis. The antibody was designed to not react with normal serum amyloid A and only with the aberrant cleaved form of the protein (amyloid A).

PRX002 for Parkinson�� Disease

The Company has generated antibodies targeting alpha-synuclein that may slow or reduce the neurodegeneration associated with synuclein misfolding and/or transmission. It has tested these antibodies in various cellular and animal models of synuclein-related disease. In a transgenic mouse model of Parkinson�� disease, passive immunization with 9E4, a murine ver! sion of PRX002, reduced the appearance of synuclein pathology, protected synapses and improved performance by the mice in behavioral testing. The humanized antibody product candidate PRX002 has advanced into manufacturing and preclinical testing.

PRX003 for Inflammatory Diseases and Cancers

The Company is developing PRX003, a monoclonal antibody targeting MCAM for the potential treatment of inflammatory diseases and cancers. It has generated monoclonal antibodies that block MCAM-mediated cell adhesion and have been shown to delay relapse and severity of relapse in a mouse model of multiple sclerosis known as experimental autoimmune encephalomyelitis. The Company�� antibodies are being tested in animal models of inflammatory diseases and cancers. Based on early results from these studies, it has identified a clinical candidate, PRX003. It has advanced this antibody into manufacturing and intends to advance this antibody into preclinical testing.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Equities Trading UP
  Prothena Corporation plc (NASDAQ: PRTA) shares shot up 21.60 percent to $45.19 after the company reported clinical data to be presented at International Symposium on Amyloidosis. Morgan Stanley raised the price target on the stock from $35.00 to $53.00.

Best Biotech Companies To Own For 2014: Redhill Biopharma Ltd (RDHL)

Redhill Biopharma Ltd. is an Israel-based biopharmaceutical company. The Company is focused on the development and acquisition of therapeutic candidates. The Company�� pipeline consists of six late clinical development therapeutic candidates, two of which have completed bioequivalence clinical trials subject to review and approval by the United States Food and Drug Administration and, in some cases, regulatory authorities in other countries. The Company�� six clinical stage therapeutic candidates include RHB-101, RHB-102, RHB-103, RHB-104, RHB-105 and RHB-106.

RHB-101

RHB-101 is a treatment of hypertension, heart failure and left ventricular dysfunction (following myocardial infraction) by means of controlled release of an active ingredient known as carvedilol, which is designed to be administered to patients on a once-daily basis. RHB-101 is based on a patented technology for the controlled release of drugs administered orally.

RHB-102

RHB-102 is a once-daily controlled release oral formulation of ondansetron. RHB-102 utilizes a technology called CDT that uses salts to provide a controlled release of ondansetron.

RHB-103

RHB-103 is an oral thin film formulation of rizatriptan intended for the treatment of acute migraine headaches. Migraine is a neurovascular disorder (related to nerves and blood vessels) characterized by recurrent headaches in one side or both sides of the head.

The product is based on a technology called VersaFilm.

RHB-104

RHB-104 is an antibiotic combination therapy for the treatment of Crohn's disease (with a PIII clinical study underway), as well as Multiple Sclerosis (with an ongoing PIIa clinical study) and Rheumatoid Arthritis. RHB-104 is a combination of clarithromycin, clofazimine and rifabutin, three generic antibiotic ingredients, in a single capsule.

RHB-105

RHB-105, an antibiotics and proton pump inhibitor drug targeting Helico! bacter Pylori infection. RHB-105 is a combination of three approved drug products omeprazole, which is a proton pump inhibitor (the natural body pump that produces the gastric acids used for digesting the food in the stomach), and amoxicillin and rifabutin which are antibiotics. Chronic infection with Helicobacter pylori irritates the mucosal lining of the stomach and small intestine.

RHB-106

RHB-106, is a tablet for the preparation and cleansing of the gastrointestinal tract prior to the performance of abdominal procedures. Its abdominal procedures include diagnostic tests, such as colonoscopy, barium enema or virtual colonoscopy, as well as surgical interventions, such as laparotomy.

The company competes with GlaxoSmithKline, Sanofi-Aventis Groupe, Hoffman-La Roche Ltd, Merck and Co., Inc, Ferring Pharmaceuticals and Salix Pharmaceuticals Inc.

Advisors' Opinion:

• [By Monica Gerson]

  Breaking news

  Vitran Corporation (NASDAQ: VTNC) announced today that it has entered into a definitive arrangement agreement with TransForce pursuant to which TransForce has agreed to acquire all of the outstanding common shares of Vitran not already owned by TransForce for US$6.50 in cash per share, in accordance with TransForce's prior proposal. To read the full news, click here. ReneSola (NYSE: SOL) today announced it signed a Memorandum of Intent (MOI) to sell three utility-scale projects in Western China, with a total capacity of 60MW, to Jiangsu Akcome Solar Science & Technology Co on December 30, 2013. To read the full news, click here. Cooper Tire & Rubber Company (NYSE: CTB) today announced it has terminated the merger agreement with Apollo Tyres (NSE:ApolloTYRE). To read the full news, click here. RedHill Biopharma (NASDAQ: RDHL) today announced that it has entered into a definitive agreement with leading healthcare investor OrbiMed Israel Partners Limited Partnership, an affiliate of OrbiMed Advisors LLC, for the sale of RedHill's American Depository Shares and warrants in a private placement transactionor a total sum of $6.0 million. To read the full news, click here.

  Posted-In: Guggenheim US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets

Best Biotech Companies To Own For 2014: Genomic Health Inc (GHDX)

Genomic Health, Inc. (Genomic Health), incorporated in August 2000, is a molecular diagnostics company focused on the global development and commercialization of genomic-based clinical laboratory services that analyze the underlying biology of cancer allowing physicians and patients to make individualized treatment decisions. Its Oncotype DX platform utilizes quantitative genomic analysis known as reverse transcription polymerase chain reaction (RT-PCR), in standard tumor pathology specimens to provide tumor-specific information, or the oncotype of a tumor. As of February 2012, Oncotype DX was evaluated in invasive breast cancer in 13 clinical studies involving more than 4,000 breast cancer patients worldwide. Genomic Health offers its Oncotype DX tests as a clinical service, where it analyzes the expression levels of genes in tumor tissue samples and provide physicians with a quantitative gene expression profile expressed as a single quantitative score, which it calls a Recurrence Score, for invasive breast cancer and colon cancer and a DCIS Score for DCIS. Its Oncotype DX breast cancer test analyzes the expression levels of 21 genes and Oncotype DX colon cancer test analyzes the expression levels of 12 genes. In March 2012, the Company established a wholly owned subsidiary, InVitae Corporation.

Oncotype DX Platform

The Company�� Oncotype DX platform uses its RT-PCR approach to improve cancer treatment decisions. Its diagnostic approach correlates gene expression to clinical outcomes and provides an individualized analysis of each patient's tumor. The Company has built a diagnostic infrastructure that allows it to move from research into development through to processing actual patient samples in its clinical reference laboratory. The Company offers Oncotype DX tests as clinical laboratory services. Its technology allows the Company to analyze tumor tissue samples in its clinical reference laboratory and provide physicians with genomic information specific to the patient'! s tumor. It analyzes tissues that are handled, processed and stored under routine clinical pathology laboratory practices.

Oncotype DX Breast Cancer Test

To develop its Oncotype DX breast cancer test, the Company evaluated 250 genes in three independent clinical studies, which identified a 21-gene panel whose composite gene expression profile can be represented by a breast cancer Recurrence Score. The Company conducted studies of its Oncotype DX breast cancer test with clinical samples from postmenopausal women with invasive breast cancer who were treated with aromatase inhibitors. In March 2010, the Journal of Clinical Oncology published results from a European study using its test to analyze tumor samples from over 1,200 patients in the ATAC (Arimedix, Tamoxifen, Alone or in Combination) trial, which established the use of aromatase inhibitors for adjuvant treatment of postmenopausal women with hormone receptor-positive breast cancer. The study demonstrated that, along with other standard measures, such as tumor size, its Oncotype DX breast cancer test contributes independently to provide a more complete picture of prognosis for N- and N+ patients treated with aromatase inhibitors.

In December 2011, the Company presented positive results from the ECOG E5194 DCIS clinical validation study at SABCS. The study met its primary endpoint by demonstrating that a pre-specified Oncotype DX DCIS Score can predict the risk of local recurrence, defined as either the development of a new invasive breast cancer or the recurrence of DCIS in the same breast. In December 2011, the Company made Oncotype DX available for patients with ductal carcinoma in situ (DCIS), of the breast, a pre-invasive form of breast cancer. The launch of Oncotype DX for DCIS patients was based on positive results presented from a clinical validation study of Oncotype DX breast cancer test in patients with DCIS, conducted by the Eastern Cooperative Oncology Group (ECOG), a clinical trials cooperative! group su! pported by the National Cancer Institute.

Oncotype DX Colon Cancer Test

The Company developed its gene panel by identifying 761 cancer-related genes through review of existing research literature and computer analysis of genomic databases. The 761 candidate genes were also examined to determine whether they would be useful beyond other key variables including tumor stage, tumor grade, lymph nodes examined and MMR/MSI. It selected a final set of 12 genes, which were then independently evaluated in a validation study of over 1,400 stage II colon cancer patients from the Quick and Simple and Reliable (QUASAR), randomized study of adjuvant chemotherapy in the United Kingdom. This international, multi-center randomized trial examined the recurrence risk and the benefit associated with 5-fluorouracil/leucovorin, or 5FU/LV, adjuvant chemotherapy. Gene expression was quantified by RT-PCR from manually microdissected FPE primary colon cancer tissue, and recurrence-free interval, disease-free survival and overall survival were analyzed. In January 2012, the Company presented positive results of the first clinical decision making study of the Oncotype DX colon cancer test that shows that Recurrence Score result has a significant impact on treatment recommendations for stage II colon cancer patients.

The Company competes with General Electric Company, Hologic, Inc., Novartis AG, Myriad Genetics, Inc., Qiagen N.V., Response Genetics, Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Roche Holding, Ltd, Siemens AG and Johnson & Johnson.

Advisors' Opinion:

• [By Sean Williams]

  What: Shares of Genomic Health (NASDAQ: GHDX  ) , a provider of genome-based clinical diagnostic tests, popped as much as 10% following the release of its first-quarter results.

• [By John Udovich]

  Large and small cap cancer stocks Gilead Sciences, Inc (NASDAQ: GILD), Celgene Corporation (NASDAQ: CELG), Veracyte (NASDAQ: VCYT), Genomic Health, Inc (NASDAQ: GHDX), Cell Therapeutics Inc (NASDAQ: CTIC) and MetaStat Inc (OTCMKTS: MTST) have all been producing a steady stream of news lately for biotech investors looking for a way to cash in on the growth in development of�cancer treatments. Just consider the following news:

• [By John Udovich]

  Small cap genomics stocks Rosetta Genomics Ltd (NASDAQ: ROSG), Genomic Health, Inc (NASDAQ: GHDX) and CollabRx Inc (NASDAQ: CLRX) are at the forefront of genomics testing�or research. I should mention that Wikipedia defines genomics�as a�discipline in genetics that applies recombinant DNA, DNA sequencing methods and bioinformatics to sequence, assemble and analyze the function and structure of genomes (the complete set of DNA within a single cell of an organism). A 2013 Booz Allen Hamilton report on the sector noted that in�2011, the US genetic and genomic clinical testing market size was estimated to be $5.9 billion while the�number of available tests has grown substantially from 1,680 just 4 years ago to 2,886 in 2012.

• [By John Udovich]

  On Tuesday, small cap cancer diagnostic stock Myriad Genetics, Inc (NASDAQ: MYGN) jumped 11.42% in one day, meaning its worth taking a closer look at the stock along with the performance of small cap cancer diagnostic stocks like Rosetta Genomics Ltd (NASDAQ: ROSG) and�Genomic Health, Inc (NASDAQ: GHDX) plus mid cap diagnostic stock Quest Diagnostics Inc (NYSE: DGX). I should mention that we have had�Myriad Genetics in our SmallCap Network Elite Opportunity (SCN EO) portfolio since February 5th and we are already up 18.50%���a nice return in just two weeks time.

Top 5 Industrial Disributor Stocks To Own For 2014

U.S. coal producer Cloud Peak Energy Inc. (CLD) released its second quarter 2013 shipment details and also updated its annual adjusted earnings before interest tax depreciation and amortization (EBITDA) guidance.

The shipments from its three operated mines totaled 20.1 million tons versus 21.1 million tons in the first quarter of 2013 and 20.1 million tons in the second quarter of 2012. The decline in coal shipments in the first half of the year did not come as a surprise as the accumulated stockpiles at the utilities delayed fresh orders.

The sequential decline in shipment of 1 million ton was attributable to weather interruptions, unplanned power plant outages at major customers, and the impact of production interruptions due to planned maintenance outages.

Cloud Peak adjusted its EBITDA guidance for 2013 and expects second quarter EBITDA to be below first quarter results. As a consequence the company decided to lower its full year EBITDA guidance at the midpoint by $15 million. Cloud Peak now expects 2013 EBITDA in the range of $210 million to $250 million.

Top 5 Mid Cap Companies To Watch For 2015: Bob Evans Farms Inc.(BOBE)

Bob Evans Farms, Inc. owns and operates full-service restaurants under the Bob Evans and Mimi's Cafe brand names in the United States. It also sells retail gifts, food items, and other novelties in its Bob Evans Restaurants, and seven Bob Evans Restaurants & General Stores. As of January 27, 2012, the company owned and operated 564 Bob Evans family restaurants in 18 states; and 145 Mimi's Caf�casual restaurants in 24 states. It also produces and distributes food products under the Bob Evans and Owens brand names. The company?s food products include fresh, smoked, and fully cooked pork sausages; hickory-smoked bacon products; refrigerated and frozen convenience food items, such as mashed potatoes, macaroni and cheese, microwaveable sandwiches, and slow-roasted main dish entrees. In addition, it owns and operates SWH Custom Foods, a prep kitchen that prepares signature muffin mixes, dressings, sauces, and soups for third-party restaurants in Fullerton, California. The com pany was founded in 1953 and is headquartered in Columbus, Ohio.

Advisors' Opinion:

• [By Sean Williams]

  Send this stock back to the kitchen
  I admit to already being hyper-critical of the restaurant industry because of cutthroat pricing practices among peers, strained consumer spending because of higher payroll taxes, and the always looming threat that food prices will soar faster than the industry can raise prices. These provide for me more than enough reasons to suggest sending Bob Evans Farms (NASDAQ: BOBE  ) back to the kitchen.

Top 5 Industrial Disributor Stocks To Own For 2014: J P Morgan Chase & Co(JPM)

JPMorgan Chase & Co., a financial holding company, provides various financial services worldwide. Its Investment Bank segment provides various investment banking products and services, including advising on corporate strategy and structure, capital-raising in equity and debt markets, risk management, market-making in cash securities and derivative instruments, prime brokerage, and research services serving corporations, financial institutions, governments, and institutional investors. The company?s Commercial Banking segment provides lending, treasury, investment banking, and asset management services to corporations, municipalities, financial institutions, and not-for-profit entities. Its Treasury & Securities Services segment offers cash management, trade, wholesale card, and liquidity products and services to small and mid-sized companies, multinational corporations, financial institutions, and government entities. It also holds, values, clears, and services securities, cash, and alternative investments for investors and broker-dealers, and manages depositary receipt programs worldwide. JPMorgan?s Asset Management segment provides investment and wealth management to institutions, retail investors, and high-net-worth individuals. This segment offers investment management in equities, fixed income, real estate, hedge funds, private equity, and liquidity products, as well as trust and estate, banking and brokerage services, and retirement services. Its Retail Financial Services segment offers retail banking and consumer lending services that include checking and savings accounts, mortgages, home equity and business loans, and investments through ATMs, online banking, and telephone banking, as well as auto dealerships and school financial-aid offices. The company?s Card Services segment issues credit cards and processes various credit card payments. JPMorgan Chase & Co. was founded in 1823 and is headquartered in New York, New York.

Advisors' Opinion:

• [By Lindsey Rupp]

  Raw-materials producers rose 1.1 percent amid speculation that tamed inflation would reduce pressure on Chinese policy makers to tighten credit. Microsoft Corp. and Intel Corp. rallied more than 3.1 percent as investors snapped up technology shares, the worst performing group this year. Alcoa Inc. was unchanged after posting earnings. J.C. Penney (JPM) Co. slumped 12 percent as it ousted Chief Executive Officer Ron Johnson and reinstated his predecessor, Myron E. Ullman III.

Top 5 Industrial Disributor Stocks To Own For 2014: CNOOC Limited(CEO)

CNOOC Limited, through its subsidiaries, engages in the exploration, development, production, and sale of crude oil, natural gas, and other petroleum products. The company?s oil and natural gas properties are located in offshore China, which include Bohai Bay, western south China Sea, eastern south China Sea, and east China Sea, as well as in Indonesia, Iraq, and other regions in Asia; and Oceania, Africa, North America, and South America. As of December 31, 2010, the company had net proved reserves of approximately 2.99 billion barrels-of-oil equivalent, including approximately 1.92 billion barrels of crude oil and 6,458.3 billion cubic feet of natural gas. It also provides bond issuance services; and has a joint venture with Bridas Energy Holdings. CNOOC Limited was founded in 1982. The company is headquartered in Central, Hong Kong, and is considered a Red Chip company due to its listing on the Hong Kong Stock Exchange. CNOOC Limited is a subsidiary of China National Of fshore Oil Corporation.

Advisors' Opinion:

• [By Stephan Dube]

  Athabasca's most notable producers:

  Suncor Energy (SU) (Part 1), see article here.Suncor Energy (Part 2), see article here.Athabasca Oil (ATHOF.PK), see article here.Canadian Natural Resources, see article here.Imperial Oil, see article here.Cenovus Energy (CVE), see article here.MEG Energy (MEGEF.PK), see article here.Devon Energy, see article here.Royal Dutch Shell, see article here.Ivanhoe Energy (IVAN), see article here.Nexen (CNOOC) (CEO), see article here.

  An analysis of the current operations of the company will be examined with the objective to provide the most complete information available to potential investors before deciding to seize the opportunity that the 54,132 square miles of the Carbonate Triangle has to offer. Let's start by introducing Athabasca, a famous and most prolific region in the Canadian oil sands as well as one of the largest reserve in the world.

Top 5 Industrial Disributor Stocks To Own For 2014: Companhia de Bebidas das Americas - AmBev(ABV)

Companhia de Bebidas das Americas?Ambev engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, malt, and other non-alcoholic and non-carbonated products in the Americas. It also sells bottled water, isotonics, and ready-to-drink teas. The company provides its products under the brand names of Skol, Brahma, Antarctica, Guarana Antarctica, Gatorade, Brahva, Brahva Beats, Extra, Brahma Light, Brahma Ice, Quilmes, Stella Artois, Red Rock, Pepsi-Cola, Seven UP, Zenda, Concordia, Triple Kola, Quilmes Cristal, Brahma, Andes, Pacena, Taquina, Huari, Becker, Baltica, Pilsen, Patricia, Labatt Blue, Alexander Keith?s, and Kokanee. It has a licensing agreement with Anheuser-Busch, Inc. to produce, bottle, distribute, and sell Budweiser products in Canada and Paraguay. Companhia de Bebidas das Americas?Ambev distributes its products through direct distribution system and third-party distributors. The company was founded in 1888 and is headquarter ed in Sao Paulo, Brazil. Companhia de Bebidas das Americas?Ambev is a subsidiary of Interbrew International B.V.

Advisors' Opinion:

• [By Hilary Kramer]

  Companhia de Bebidas das Americas (ABV): Better known as Ambev, it is one of the largest brewers in the world and the largest in Latin America (in terms of sales volume). It makes a variety of beverages, including beer and soft drinks, and is also one of the biggest independent PepsiCo bottlers in the world. The company has done a good job lately of emphasizing premium beers, which carry a higher margin, to offset recent lower sales volumes. ABV yields a solid 4.6%.

• [By Dividend]

  Companhia de Bebidas Das Americas (ABV) has a market capitalization of $118.32 billion. The company employs 51,299 people, generates revenue of $14.120 billion and has a net income of $4.662 billion. Companhia de Bebidas Das Americas�� earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $6.829 billion. The EBITDA margin is 48.36 percent (the operating margin is 43.00 percent and the net profit margin 33.02 percent).

Top 5 Industrial Conglomerate Companies To Watch In Right Now

Travelers (NYSE: TRV  ) has traveled north of the border for its latest large-scale asset purchase. The company announced Monday that it has agreed to a deal with Canada's E-L Financial to acquire The Dominion of Canada General Insurance.

The price is roughly $1.1 billion in cash, although the final amount is subject to adjustment.

In the press release announcing the news, Travelers quoted CEO Jay Fishman as saying that Dominion is "a great franchise, and this is a very good opportunity for Travelers to significantly improve its market position and scale in a meaningful market."

The American firm said Dominion's Canadian operations would be integrated with its own in that country, and the blended firms would have their headquarters in Toronto. Dominion's current CEO, Brigid Murphy, will serve in the same capacity for the combined entity. The Dominion was founded in 1887 in Toronto and has expanded across Canada. The transaction is expected to close in the fourth quarter.

Top 5 Industrial Conglomerate Companies To Watch In Right Now: Wartsila Oyj Abp (WRT1V.HE)

Wartsila Oyj Abp is a Finland-based company. Its operations are divided into four segments: Power Plants, Ship Power, Services and PowerTech. The Power Plants segment offers multi-fuel solutions for power generation markets, such as gas power plants, dual-fuel power plants, oil power plants and liquid biofuel power plants, among others. The Ship Power segment offers a range of products and services to both shipyards and ship owners, such as medium-speed and low-speed engines, seals and bearings, automation systems, ship design and ballast water treatment systems, among others. The Services segment offers solutions, such as basic support, installation and commissioning, performance optimization and upgrades, among others. The PowerTech segment comprises research and development for medium-speed engines and other operations, with a focus on gas, environmental solutions and Smart Power Generation drives. It has operations in more than 160 locations in over 70 countries around the world. Advisors' Opinion:

• [By Robert Wall var popups = dojo.query(".socialByline .popC"); popups.forEach(fu]

  The British company tried to strengthen its maritime engine business through a $10 billion takeover of Finland�� W盲rtsil盲 Oyj (WRT1V.HE) which rebuffed Rolls-Royce’s preliminary approach. The attempted acquisition of a company of that size surprised investors who hadn�� realized expansion was on management�� agenda so soon after its full takeover of Tognum, a German engineering company originally acquired in partnership with Daimler.

Top 5 Industrial Conglomerate Companies To Watch In Right Now: ThyssenKrupp AG (TKA)

ThyssenKrupp AG is a Germany-based technology holding company operating in seven business areas. The Steel Europe division produces carbon steel flat products. The Steel Americas division is engaged in production, processing and marketing of high-grade carbon steels. The Materials Services division is engaged in global distribution of materials and the provision of complex technical services for the production and manufacturing sectors. The Elevator Technology division is engaged in the area of passenger transportation systems. The Plant Technology division focuses on specialty and large-scale plant construction. The Components Technology division is engaged in manufacturing components for the automotive, construction and engineering sectors as well as for wind turbines. The Marine Systems division focuses on naval and civil shipbuilding. Apart from its business areas, it provides business services, which are diversified into Business Services and Information Technology (IT) Services. Advisors' Opinion:

• [By Corinne Gretler]

  Telekom Austria (TKA) slid 1.6 percent to 5.63 euros. Second-quarter earnings before interest, taxes, depreciation and amortization fell to 330.3 million euros ($439 million) from 364.8 million euros a year earlier. That compared with the average 332.7 million-euro analyst estimate.

• [By Sofia Horta e Costa]

  ThyssenKrupp AG (TKA), Germany�� largest steelmaker, rose to a five-week high. YOC AG (YOC) surged the most in more than three months after the mobile-phone advertising company said it sold 1.3 million euros ($1.7 million) of shares to increase capital. Lanxess AG (LXS), the chemical maker that joined the DAX in September, retreated 3.4 percent.

• [By Corinne Gretler]

  ThyssenKrupp AG (TKA) slumped 9.3 percent after Germany�� largest steelmaker raised 882.3 million euros ($1.21 billion) through a share sale. Standard Chartered Plc lost 8.1 percent. Sage Group (SGE) Plc, the U.K.�� biggest software maker, rose 6.8 percent after reporting revenue growth that exceeded analysts��estimates. AZ Electronic Materials SA surged 43 percent after Merck KGaA (MRK) agreed to buy it for about 1.6 billion pounds ($2.6 billion).

Best Japanese Companies To Buy For 2015: Kawasaki Heavy Industries Ltd (KWHIY)

Kawasaki Heavy Industries Ltd (KHI), incorporated on October 15, 1896, is a global manufacturer of transportation equipment and industrial goods. KHI manufactures ships, rolling stock, aircraft and jet engines, gas turbine power generators, environmental and industrial plants, and range of manufacturing equipment and systems. KHI also produces consumer products, such as Kawasaki-brand motorcycles and personal watercraft. KHI�� business is divided into seven operations: shipbuilding, rolling stock and construction machinery, aerospace, gas turbines and machinery, plant and infrastructure engineering, consumer products and machinery, and hydraulic machinery.

Kawasaki Shipbuilding Corporation, which is the company of this segment, is engaged in building gas carriers and submarines, which require advanced design and construction technologies. It offers

a range of liquefied natural gas (LNG) carriers, extending from small carriers with cargo tank capacities of 19,000 cubic meters to large carriers with capacities of 177,000 cubic meters. It also developed and offered in its lineup a pressure build-up type LNG carrier for short distance and small-volume transportation. The Company�� shipbuilding operations include products, such as LNG carriers, liquefied petroleum gas (LPG) carriers, container ships, very large crude carriers (VLCCs) and other types of tankers, bulk carriers, high speed vessels, submarines, maritime application equipment.

KHI�� rolling stock production systems are located in Hyogo and Harima in Japan and in Lincoln, Nebraska, and Yonkers, New York, in United States. Kawasaki completed its light rail vehicle (LRV), dubbed SWIMO. It also is developing efSET (Environmentally Friendly Super Express Train) which achieves a service speed of 350 kilometers per hour (km/h). Regarding the construction machinery business, Kawasaki has arranged a business alliance with Hitachi Construction Machinery Co., Ltd., and TCM Corporation. As of April 1, 2009, the Compa! ny split off its construction machinery business as a wholly owned subsidiary of KHI, KCM Corporation.

KHI is the prime contractor for the development of the MOD�� large-scale XP-1 and C-X aircraft. In the commercial aircraft field, KHI delivered a test model of Boeing�� 787 Dreamliner passenger aircraft. KHI is a partner corporation in the development and production of the 787 Dreamliner.

The Gas Turbines & Machinery segment has a range of products for the energy and transportation equipment field. KHI focuses to expand its global business by offering solutions for its customers that include a lineup of in-house developed gas turbines together with product support and maintenance. During the year ended December 31, 2008, the 8MW-class power-generating capacity Kawasaki Green Gas Engine had 4,000 hours of operational testing.

The plant and infrastructure engineering segment encompasses the operations of Kawasaki Plant Systems, Ltd. (K Plant), which undertakes projects to supply energy-related, industrial infrastructure, environmental preservation systems and equipment, and the operations of the parent company�� Industrial Facilities and Tunneling Equipment Division, which mainly focuses on LNG tanks and diverse other storage tanks along with shield machines and tunnel-boring machines. The Anhui Conch Kawasaki Energy Conservation Equipment Manufacturing Co., Ltd. (CKM) is engaged in the manufacturing of PH boiler parts that are employed in waste heat power plants. CKM has commenced the manufacturing and sales of environmental preservation related products, including cement plant components, such as vertical mills, boilers for waste heat recovery power generation systems, and waste gasification systems and sewage treatment systems that can be integrated with cement kilns to enable municipal waste recycling.

The consumer products and machinery segment includes the manufacture of motorcycles, all terrain vehicles (ATVs), utility vehicles, personal! watercra! ft, general purpose gasoline engines and industrial robots. In the motorcycle line, Kawasaki launched the ZRX1200 DAEG and the Ninja ZX-6R. In the cruiser segment, Kawasaki launched its Vulcan 1700 series with developed engine and chassis. This series includes the Vulcan 1700 Voyager, a full-dress V-twin engine tourer with a load of long-distance touring equipment. In the utility vehicle category, KHI equipped the Teryx 750 series with an electronic fuel injection system, mainly for recreational use. The MULE utility-oriented vehicle series was restyled with the launch of the MULE 4010 series.

The hydraulic machinery operations include Kawasaki Precision Machinery Ltd. (KPM). It has five manufacturing and marketing facilities, which comprises KPM�� headquarters plant and the facilities

of Kawasaki Precision Machinery (U.K.) Limited; Kawasaki Precision Machinery (U.S.A.), Inc.; China based Kawasaki Precision Machinery (Suzhou) Ltd.; and Korea-based Flutek, Ltd.

Advisors' Opinion:

• [By WWW.MARKETWATCH.COM]

  LOS ANGELES (MarketWatch) -- Japanese stocks have ended with losses in every session this week, and sure enough, the Nikkei Average (JP:NIK) was down 0.6% in early Friday trade, though off an opening 0.8% defecit, while the Topix carried a 0.7% loss. Overnight losses for the U.S. and further strength in the yen (with the dollar falling to 楼101.28 from 楼101.56 a day earlier) helped drag the market lower, as did results from Fast Retailing Co. (JP:9983) (FRCOF) , the shares of which hold the heaviest weighting on Nikkei Average. Fast Retailing said that while its Uniqlo brand was doing great business, weakness for its J Brand luxury demin label helped send September-May profit down 4% and prompted another cut to Fast's full-year outlook. Consequently, its shares traded 0.7% lower, though rivals Takashimaya Co. (JP:8233) and J. Front Retailing Co. (JP:3086) (JFROF) also saw losses of 0.6% and 0.5%, respectively. Among other decliners, Sony Corp. (JP:6758) (SNE) lost 0.7%, Toshiba Corp. (JP:6502) (TOSYY) fell 2.1%, Kawasaki Heavy Industries Ltd. (JP:7012) (KWHIY) fell 1.5%, Toyota Motor Corp. (JP:7203) (TM) and Nissan Motor Co. (JP:7201)

Top 5 Industrial Conglomerate Companies To Watch In Right Now: Orkla ASA (ORK)

Orkla ASA is a Norway-based company active in various sectors. The Company�� operations are structured into two segments: Branded Consumer Goods and Other Businesses. The Branded Consumer Goods segment is divided into five units: Orkla Foods, which comprises the Company�� food businesses in the Nordic region and the Baltics; Orkla Confectionery, which comprises five branded consumer goods businesses which serve the Nordic region and the Baltics as their home markets; Orkls Home & Personal consists of five branded consumer goods businesses, including Lilleborg, Lilleborg Profesjonell, the Axellus Group, Pierre Robert Group and House Care; Orkla Food Ingredients cover product categories, including margarine, marzipan, bread improvers and mixes, and yeast, and Orkla International includes branded consumer goods companies outside the Nordic region and the Baltics. The Other Businesses segment covers the Company�� operation in aluminum, real estate and hydropower sectors, among others. Advisors' Opinion:

• [By Jonathan Morgan]

  Orkla ASA (ORK), the Norwegian industrial conglomerate transforming itself into a consumer-goods producer, slumped 11 percent to 46.78 kroner, the largest drop since November 2011. The company reported second-quarter pretax profit of 514 million kroner ($86 million), missing estimates of 965 million kroner in a Bloomberg survey of analysts.

Top 5 Industrial Conglomerate Companies To Watch In Right Now: Hitachi Ltd (HTHIF)

Hitachi, Ltd. is a diversified company. Information and Telecommunication System segment offers system integration services and automated teller machines. Electricity System segment offers power generation systems. Social and Industrial System segment offers industrial machinery. Electronic Device and System segment offers liquid crystal displays. Construction segment offers hydraulic shovels and wheel loaders. High Functional Material segment offers electric wires and cables. Automotive System segment offers engine management and in-car information systems. Component and Device segment offers information record media and batteries. Digital Media and Consumer Product segment offers optical disk drives and refrigerators. Financial Service segment offers leasing and loan services. On March 1, 2014, it fully acquired Hitachi Medical Corp. On April 1, 2014, it transferred and integrated its air conditioning systems construction, and elevator and escalator businesses into two subsidiaries. Advisors' Opinion:

• [By MARKETWATCH]

  LOS ANGELES (MarketWatch) -- Japanese stocks rose as trading began Wednesday, with the Nikkei Stock Average (JP:NIK) climbing 1.7% to 15,234.83, a strong advance after four days of declines. Aiding the export-heavy market was a rise in the U.S. dollar against the yen above the 楼103 level as the yen's safe-haven appeal waned alongside worries about emerging markets. Among exporters, Honda Motor Co. (JP:7267) (HMC) and Toyota Motor Corp. (JP:7203) (TM) shares tacked on 2.4% and 1.5%, respectively, and Hitachi Ltd. (JP:6501) (HTHIF) shot higher by 4.8%. But shares of Advantest Corp. (JP:6857) (ADTTF) dropped 9.3% after the electronics maker widened its full-year forecast. It now expects a net loss of 35.9 billion yen ($347.19 million), compared with a previous forecast for a loss of 2.5 billion yen.

• [By MARKETWATCH]

  LOS ANGELES (MarketWatch) -- Japanese stocks struggled early Thursday, keying off a weak close for Wall Street on investor concerns about a pullback in monetary stimulus. The Nikkei Stock Average (JP:NIK) shed 25 points, or 0.2%, to 15,889.77, and the broader Topix shed less than 0.1%. Yen strength on Wednesday left the Nikkei with its first loss in five sessions. Outperforming the broader market Thursday were shares of Hitachi Ltd. (JP:6501) (HTHIF) as they climbed 1.6%. The U.K. government has agreed to support loan financing for Hitachi's development of a new nuclear power reactor at an existing nuclear power station on the island of Anglesey, North Wales.

Top 10 Gas Utility Stocks To Buy For 2014

Buying Berkshire Hathaway (BRK.B) always has seemed like a leap of faith–you either believed in Warren Buffett’s omnipotence or you didn’t–that having an analyst cover the company always seemed beside the point. But analysts do cover Berkshire Hathaway, and one of them even had something to say about the company today.

AFP

That would Barclays’ Jay Gelb, who released a big report on Berkshire Hathaway today. And wouldn’t you know it, not only does he like Warren Buffett’s baby, he thinks now would be a good time to buy. Gelb explains why:

Berkshire�� insurance businesses generates substantial no-cost float ($77bn at YE13) available for investing and will benefit from the Heinz acquisition. Importantly, Berkshire has significant cash available for additional acquisitions (we estimate ~$25bn) to supplement organic growth…

Top 10 US Companies To Own In Right Now: Zogenix Inc (ZGNX)

Zogenix, Inc. (Zogenix), incorporated on May 11, 2006, is a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain. The Company�� product Sumavel DosePro offers needle-free subcutaneous administration of sumatriptan for the treatment of migraine and cluster headache in a pre-filled, single-use delivery system. Its lead product candidate, Zohydro (hydrocodone bitartrate, formerly ZX002) is a 12-hour extended-release formulation of hydrocodone without acetaminophen for the treatment of chronic pain requiring opioid therapy. It completed Phase 3 development of Zohydro in 2011. Its second DosePro investigational product candidate, Relday, is a injectable formulation of risperidone for the treatment of schizophrenia. Sumavel DosePro and Zohydro are used for the treatment options available to patients and physicians in the United States. Sumavel DosePro may serve as a treatment alternative to oral and nasal triptans and offers administration when compared to traditional, needle-based sumatriptan injection. In May, 2012, it submitted a New Drug Application to the Food and Drug Administration (FDA).

The Company�� collaboration with Astellas has been terminated on March 31, 2012. Sumavel DosePro is a pre-filled, single-use disposable, needle-free drug delivery system that subcutaneously delivers 6 mg of sumatriptan in 0.5 mL of sterile liquid. Sumavel DosePro is designed to be portable, intuitive and easy-to-use. To use, the patient simply snaps off a plastic tip, flips back a lever and presses the end of the delivery system to the skin of the abdomen or thigh. Under the force of a small amount of compressed nitrogen gas, the liquid form of sumatriptan is expelled out of the device as a thin jet of medication, which pierces the skin and selectively deposits into the subcutaneous tissue.

Zogenix competes with GlaxoSmithKline, AstraZeneca PLC, Endo Pharmaceuticals Holdings Inc., Johnson & Johnson, Merck & Co., ! Inc., Pfizer Inc., Alexza Pharmaceuticals, Inc., MAP Pharmaceuticals, Inc., Abbott Laboratories, Alpharma Inc., Endo Pharmaceuticals Holdings Inc., King Pharmaceuticals, Inc., Mallinckrodt Inc., Purdue Pharma L.P., Teva Pharmaceutical Industries Limited, Watson Pharmaceuticals, Inc., Becton, Dickinson and Company, Owen Mumford Ltd., Ypsomed, Sandoz Inc., Bioject Inc. and Antares Pharma Inc.

Advisors' Opinion:

• [By Sean Williams]

  What: Shares of Zogenix (NASDAQ: ZGNX  ) , a biopharmaceutical company developing therapies to treat central nervous system disorders and pain, jumped as much as 15% after updating the status of its severe pain medication Zohydro ER in Massachusetts.

• [By Monica Gerson]

  Zogenix (NASDAQ: ZGNX) shares gained 9.21% to $3.32 in the pre-market session after the company won the FDA approval for Zohydro ER capsules.

  Ariad Pharmaceuticals (NASDAQ: ARIA) soared 5.06% to $3.74 in the pre-market trading. ARIAD Pharmaceuticals is expected to report its Q3 financial results on November 6, 2013.

• [By Lauren Pollock]

  The Food and Drug Administration approved an extended-release version of the narcotic painkiller hydrocodone despite a recommendation by its advisory committee that the drug should be rejected because of its potential for abuse. The federal agency approved Zohydro ER from Zogenix Inc.(ZGNX), the first hydrocodone product not mixed with milder painkillers such as acetaminophen and also the first extended-release hydrocodone product. Shares rose 15% to $3.49 premarket.

Top 10 Gas Utility Stocks To Buy For 2014: Samson Oil and Gas Ltd (SSN)

Samson Oil & Gas Limited (Samson), incorporated on April 6, 1979, is engaged in exploration and development of oil and natural gas properties in the United States. Samson owns a working interest in each of its three material producing properties, through which it has entered into operating agreements with third parties under which the oil and gas are produced and sold. The Company also has 100% working interest in one exploration property and 50% to 100% in a second property. As of June 30, 2012, the Company�� properties included North Stockyard Project; State GC Oil and Gas Field, New Mexico; Davis Bintliff (Sabretooth Prospect), Brazoria County, Texas; Hawk Springs Project, Goshen County, Wyoming, and Roosevelt Project, Roosevelt County, Montana. As of June 30, 2012, the Company along with its subsidiaries produced approximately 87,956 barrels of oil and 214,463 thousand cubic feet of gas.

North Stockyard Project -Williston Basin, North Dakota

Samson has 34.5% working interest in 3,303 acres adjacent to the North Stockyard Oil Field, which is located in the Williston Basin in North Dakota and is operated by Zavanna LLC. Together with the Company�� working interest owners, it has drilled seven wells in this field, six in the Bakken formation and one in the Mission Canyon formation. During July 2012, the Harstad #1-15H well averaged 15 barrels of oil per day (BOPD). The Leonard-23H (10% working interest, 37.5% after non-consent penalty) is a Mississippian Middle Bakken Formation. In July 2011, this well averaged 46 barrels of oil per day. The Company drilled its third Bakken well in the North Stockyard Field, the Gary-24H (37% working interest). During July 2012, this well averaged 75 BOPD. It drilled its fourth Bakken well in the North Stockyard Field, the Rodney-14H (27% working interest). In July 2011, this well averaged 92 BOPD. It drilled its fifth Bakken well in the North Stockyard Field in Williams County, North Dakota, the Earl 1-13H (32% working interest). In Jul! y 2011, the well averaged 193 BOPD. In June 2011, it drilled its sixth Mississippian Bakken well in the North Stockyard field in Williams County, North Dakota, the Everett 1-15H (26% working interest). As of June 30, 2012, the North Stockyard project had net proved reserves of 598,500 barrels of oil and 757,800 thousand cubic feet (of natural gas).

State GC Oil and Gas Field, New Mexico

The State GC oil and gas field is located in Lea County, New Mexico, and covers approximately 600 acres. As of June 30, 2012, the field had two wells, the State GC#1 and State GC#2. Average daily production during the year ended June 30, 2012 from the State GC oil and gas field was approximately 43 BOPD and 37 million standard cubic feet per day. As of June 30, 2012, the State GC oil and gas field had net proved reserves of 65,500 barrels of oil and 87,300 thousand cubic feet (of natural gas).

Davis Bintliff #1 Well (Sabretooth Prospect), Brazoria County, Texas

The Davis Bintliff #1 well is operated by Davis Holdings. During the year ended June 30, 2012, this well averaged 29 BOPD and 2.61million cubic feet per day. As of June 30, 2012, the Davis Bintliff well had net proved reserves of 700 barrels of oil and 66,400 Thousand cubic feet (of natural gas).

Hawk Springs Project, Goshen County, Wyoming

The Company has 37.5%-100% working interest in Hawk Springs Project. The Spirit of America 1 replacement well, Spirit of America 2, was successfully drilled to a total depth of 10,634 feet during the fiscal year ended June 30, 2012 (fiscal 2012).

Roosevelt Project, Roosevelt County, Montana

The well was drilled to a total measured depth of 14,972 feet with the horizontal lateral remaining within the target zone for the entire lateral length. approximately 3,425 barrels of oil have been produced.

Advisors' Opinion:

• [By James E. Brumley]

  Had Samson Oil & Gas Limited (NYSEMKT:SSN) made the late-July surge and subsequent early-August pullback and then gotten stuck in the mud again, I might not even bother taking a look at it. That's not how it happened though. Since the pullback, SSN has perked up again, perhaps not as hot as it was with the initial rally at the end of last month, but more than hot enough to get my attention. I suspect another surge - perhaps a longer-lasting surge - is in the cards.

Top 10 Gas Utility Stocks To Buy For 2014: Questcor Pharmaceuticals Inc.(QCOR)

Questcor Pharmaceuticals, Inc., a biopharmaceutical company, provides prescription drugs for the treatment of auto-immune diseases. The company?s primary product is H.P. Acthar Gel (repository corticotropin injection), an injectable drug for the treatment of acute exacerbations of multiple sclerosis; infantile spasms in infants and children under two years of age; nephrotic syndrome; and Lupus. Questcor Pharmaceuticals, Inc. was founded in 1990 and is headquartered in Anaheim, California.

Advisors' Opinion:

• [By Sean Williams]

  What: Shares of Questcor Pharmaceuticals (NASDAQ: QCOR  ) , a specialty biopharmaceutical company, skyrocketed as much as 37% after the company announced a deal to purchase Synacthen and Synacthen Depot in the U.S. from Novartis (NYSE: NVS  ) .

• [By Seth Jayson]

  Questcor Pharmaceuticals (Nasdaq: QCOR  ) reported earnings on April 30. Here are the numbers you need to know.

  The 10-second takeaway
  For the quarter ended March 31 (Q1), Questcor Pharmaceuticals whiffed on revenues and whiffed on earnings per share.

Top 10 Gas Utility Stocks To Buy For 2014: HD Supply Holdings Inc (HDS)

HD Supply Holdings, Inc., incorporated on June 18, 2007, is an industrial distributor in North America. It operates in four segments: Facilities Maintenance, Waterworks, Power Solutions and White Cap. Facilities Maintenance distributes maintenance, repair and operations (MRO) products, provides value-add services and fabricates custom products to multifamily, hospitality, healthcare and institutional facilities. Waterworks distributes complete lines of water and wastewater transmission products, serving contractors and municipalities in the water and wastewater industries for non-residential and residential uses. Power Solutions distributes electrical transmission and distribution products, power plant MRO supplies and smart-grid products, and arranges materials management and procurement outsourcing for the power generation and distribution industries. White Cap distributes specialized hardware, tools, engineered materials and safety products to non-residential and residential contractors.

Maintenance, Repair & Operations

In the Maintenance, Repair & Operations market sector, the Company�� Facilities Maintenance, Crown Bolt and Repair & Remodel business units serve customers across multiple industries by primarily delivering supplies and services needed to maintain and upgrade multifamily, hospitality, healthcare and institutional facilities. Facilities Maintenance and Crown Bolt are distribution center based models, while Repair & Remodel operates through retail outlets primarily serving cash and carry customers.

Infrastructure & Power and Specialty Construction

In the Infrastructure & Power market sector, Waterworks and Power Solutions support both established infrastructure and new projects by meeting demand for critical supplies and services used to build and maintain water systems and electrical power generation, transmission and distribution infrastructure. In the Specialty Construction market sector, White Cap and Creative Touch Interiors (! CTI) serve professional contractors and trades by meeting their distinct and customized supply needs in non-residential, residential and industrial applications. White Cap is its primary business unit serving this sector through the broad national presence of its regionally organized branch distribution network.

Advisors' Opinion:

• [By Mani]

  The long-term set up for HD Supply Holdings Inc (NASDAQ:HDS) appears to be favorable, primarily driven by prospective U.S. non-residential construction recovery and rapid balance sheet deleveraging in the future.

Top 10 Gas Utility Stocks To Buy For 2014: Royal Dutch Shell PLC (RDS.B)

Royal Dutch Shell plc (Shell), incorporated on February 5, 2002, is an independent oil and gas company. The Company owns, directly or indirectly, investments in the numerous companies constituting Shell. Shell is engaged worldwide in the principal aspects of the oil and gas industry and also has interests in chemicals and other energy-related businesses. The Company operates in three segments: Upstream, Downstream and Corporate. Upstream combines the operating segments Upstream International and Upstream Americas, which are engaged in searching for and recovering crude oil and natural gas; the liquefaction and transportation of gas; the extraction of bitumen from oil sands that is converted into synthetic crude oil, and wind energy. Downstream is engaged in manufacturing; distribution and marketing activities for oil products and chemicals, in alternative energy (excluding wind), and carbon dioxide (CO2) management. Corporate represents the key support functions, comprising holdings and treasury, headquarters, central functions and Shell�� self-insurance activities. In October 2011, the Company bought a marine terminal on Canada's Pacific Coast as a possible site for a liquefied natural gas export terminal. In January 2012, the Company's 50% owned, Australia Arrow Energy Holdings Pty Ltd acquired all of the shares in Bow Energy Ltd. In January 2014, Royal Dutch Shell plc completed the acquisition of Repsol S.A.'s liquefied natural gas (LNG) portfolio outside North America.

Upstream International manages the Upstream businesses outside the Americas. It searches for and recovers crude oil and natural gas, liquefies and transports gas, and operates the upstream and midstream infrastructure necessary to deliver oil and gas to market. Upstream International also manages Shell�� entire liquefied petroleum gas (LNG) business, gas to liquids (GTL) and the wind business in Europe. Its activities are organized primarily within geographical units, although there are some activities that are mana! ged across the businesses or provided through support units.

Upstream Americas manages the Upstream businesses in North and South America. It searches for and recovers crude oil and natural gas, transports gas and operates the upstream and midstream infrastructure necessary to deliver oil and gas to market. Upstream Americas also extracts bitumen from oil sands that is converted into synthetic crude oil. Additionally, it manages the United States-based wind business. It comprises operations organized into business-wide managed activities and supporting activities.

Downstream manages Shell�� manufacturing, distribution and marketing activities for oil products and chemicals. These activities are organized into globally managed classes of business, although some are managed regionally or provided through support units. Manufacturing and supply includes refining, supply and shipping of crude oil. Marketing sells a range of products including fuels, lubricants, bitumen and liquefied petroleum gas (LPG) for home, transport and industrial use. Chemicals produces and markets petrochemicals for industrial customers, including the raw materials for plastics, coatings and detergents. Downstream also trades Shell�� flow of hydrocarbons and other energy-related products, supplies the Downstream businesses, markets gas and power and provides shipping services. Downstream additionally oversees Shell�� interests in alternative energy (including biofuels, and excluding wind) and CO2 management.

Projects and Technology manages the delivery of Shell�� major projects and drives the research and innovation to create technology solutions. It provides technical services and technology capability covering both Upstream and Downstream activities. It is also responsible for providing functional leadership across Shell in the areas of health, safety and environment, and contracting and procurement.

Advisors' Opinion:

• [By Sara Sjolin]

  Oil prices were also lower, weighing on the U.K. oil firms. Shares of Royal Dutch Shell PLC (UK:RDSB) � (RDS.B) �gave up 0.9%, BG Group PLC (UK:BG) �shed 0.4% and BP PLC (UK:BP) � (BP) �lost 0.2%.

Top 10 Gas Utility Stocks To Buy For 2014: Akbank TAS (AKBNK)

Akbank TAS (Akbank) is a Turkey-based commercial bank. The Bank operates in five segments: the Retail banking segment offers a range of retail services, such as deposit accounts, consumer loans, commercial installment loans, credit cards, insurance products and asset management services; the Corporate and Small and Medium Size Enterprises (SME) banking segment provides financial solutions and banking services to large, medium and small size corporate and commercial customers; the Treasury Activities segment conducts regional and foreign currency spot and forward transactions, treasury bonds, government bonds, Eurobond and private sector bond transactions, as well as derivative trading activities; the Private banking segment offers banking and investment transactions for upper-income groups, and the International banking segment provides services for foreign trade financing, foreign currency and Turkish Lira (TL) clearances, and money transfers through agent financial institutions. Advisors' Opinion:

• [By Harry Suhartono]

  The Borsa Istanbul National 100 Index jumped 3.7 percent, the most among major emerging-market gauges, as Akbank TAS (AKBNK) and Turkiye Halk Bankasi AS (HALKB) rallied. Benchmark measures in Poland and the Czech Republic added at least 0.5 percent, while Hungarian shares retreated for a fourth day.

• [By Julia Leite]

  Turkey�� equity benchmark rallied as Turkiye Garanti Bankasi AS and Akbank TAS (AKBNK) advanced at least 5.4 percent. The lira gained for the fourth day.

• [By Anuchit Nguyen]

  The Borsa Istanbul National 100 Index capped the longest slide since July 26 as Akbank TAS (AKBNK) and Turkiye Garanti Bankasi AS dropped at least 2.9 percent.

Top 10 Gas Utility Stocks To Buy For 2014: Onconova Therapeutics Inc (ONTX)

Onconova Therapeutics, Inc. (Onconova), incorporated on December 22, 1998, is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways, which promote cancer. It has three clinical-stage product candidates and six preclinical programs. Its preclinical pipeline includes six programs, which target kinases, cellular metabolism or division.

Rigosertib

Rigosertib, the Company�� product candidate, is being tested in a range of ongoing Phase-II and Phase-III clinical trials. The Company is conducting a pivotal phase-III trial of rigosertib under a Special Protocol Assessment (SPA), from the United States Food and Drug Administration (FDA), for higher risk myelodysplastic syndromes (MDS). The Company is also evaluating rigosertib in a Phase-III trial for metastatic pancreatic cancer, in two Phase-II trials for transfusion-dependent lower risk MDS, and in a Phase-II trial for head and neck cancers. Rigosertib has been granted orphan drug status for MDS in both the United States and Europe, as well as orphan drug status for pancreatic cancer in the United States. Baxter Healthcare SA (Baxter), a subsidiary of Baxter International Inc., has commercialization rights for rigosertib in Europe and SymBio Pharmaceuticals Limited (SymBio), has commercialization rights in Japan and Korea. Rigosertib is an inhibitor of two cellular signaling pathways: phosphoinositide 3-kinase (PI3K), and polo-like kinase (PLK), both of which are frequently over-active in cancer cells. By inhibiting the PI3K pathway in cancer cells, rigosertib promotes tumor cell apoptosis, or programmed cell death. It is testing both intravenous and oral formulations of rigosertib, referred to as rigosertib IV and rigosertib Oral, in clinical trials.

ON 013105

The Company�� clinical-stage product candidate, ON 013105, is i! n a Phase I trial in patients with relapsed or refractory lymphoma, including an aggressive form of non-Hodgkin's lymphoma identified as mantle cell lymphoma (MCL), and acute lymphoid leukemia (ALL). ON 013105 suppresses the accumulation of cyclin D1 in cancer cells.

Recilisib

The Company�� clinical-stage product candidate, recilisib, is being developed in collaboration with the United States Department of Defense (DoD), for acute radiation syndromes (ARS). The Company has completed four Phase-I trials to evaluate the safety and pharmacokinetics of recilisib in healthy human adult subjects using both subcutaneous and oral formulations, referred to as recilisib SC and recilisib Oral.

Preclinical Programs

The Company�� ON 1231320 is a specific inhibitor of Polo-like Kinase 2 (PLK2), and in preclinical studies, it induced mitotic arrest and reduced tumor burden in mice injected subcutaneously with colon tumor and triple-negative breast cancer cells. The Company�� ON 123300 inhibits the activity of two kinases, cyclin-dependent kinase 4 (CDK4), and AMP-activated protein kinase 5 (ARK5). Its ON 108600 is a dual inhibitor of two growth-regulatory kinases. Cyclin-dependent kinase 9 is over expressed in several cancers, including leukemias and lymphomas. Casein kinase 2 is overexpressed in a range of tumor types. ON 044580 inhibits mutant forms of the two target kinases, including Janus Kinase 2 (JAK2) and imatinib-resistant Bcr-Abl Kinase (Bcr-Abl). Its ON 24 compounds cause tubulin to depolymerize, inducing mitotic arrest in cultured tumor cell lines. Its ON 146040 inhibits the growth of a range of blood cancer cell lines, including Burkitt's lymphoma, MCL, multiple myeloma and chronic myeloid leukemia.

The Company competes with Eisai Inc., Celgene Corporation, Genentech, Inc., Cell Therapeutics, Inc., Cyclacel Pharmaceuticals, Inc., Telik, Inc., Spectrum Pharmaceuticals, Inc., Astex, Array BioPharma Inc., Astellas Pharma, Inc., Threshold! Pharmace! uticals, Inc., Pharmacyclics Inc., Soligenix, Inc., Cellerant Therapeutics, Inc. and Cleveland BioLabs, Inc.

Advisors' Opinion:

• [By Roberto Pedone]

   

  Onconova Therapeutics (ONTX), a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule drug candidates to treat cancer. This stock closed up 2.5% to $5.15 in Thursday's trading session.

   

  Thursday's Range: $4.97-$5.19
  
  52-Week Range: $4.10-$31.13
  
  Thursday's Volume: 132,000
  
  Three-Month Average Volume: 216,102

   

  From a technical perspective, ONTX trended modestly higher here with lighter-than-average volume. This stock has been uptrending over the last few weeks, with shares moving higher from its low of $4.10 to its recent high of $5.52. During that uptrend, shares of ONTX have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of ONTX within range of triggering a near-term breakout trade. That trade will hit if ONTX manages to take out Thursday's intraday high of $5.19 to some more key overhead resistance at $5.52 with high volume.

   

  Traders should now look for long-biased trades in ONTX as long as it's trending above some near-term support levels at $4.80 or at $4.50 and then once it sustains a move or close above those breakout levels with volume that hits near or above 216,102 shares. If that breakout gets underway soon, then ONTX will set up to re-test or possibly take out its next major overhead resistance levels at $5.83 to $6.27. Any high-volume move above those levels will then give ONTX a chance to tag $7.

   

Best Supermarket Stocks To Watch Right Now

There are those glorious days in life, when you walk into the supermarket to buy cereal, and at the checkout, the guy ringing you up says, "You know these are buy one, get two free?" Really? How is that possible? you think. Well, I guess I'd be a fool not to take advantage. Then you wander home, smiling at your good fortune.

Microsoft (NASDAQ: MSFT  ) feels like that right now.

After a disappointing earnings release, including an acknowledgment of weakness in Surface sales, the company's stock tanked, falling 12% over the next day. The company is now trading at a P/E of just 12, even though revenue, operating income, and earnings per share all increased over the previous year. If now isn't the time to buy Microsoft, I'm not sure there will ever be a time.

The state business
No one needs to kid himself into thinking that things are as they've always been. PC sales are dropping like greased watermelons, and the companies that support PCs are generally doing poorly. Intel (NASDAQ: INTC  ) is forecasting 2013 sales to be level with the previous year, and second-quarter income fell almost 30%, the company announced last week. The chipmaker isn't the only one suffering, as computer manufacturers and software companies have floundered as well.

Top 5 European Companies To Buy For 2015: Citi Trends Inc (CTRN)

Citi Trends, Inc., incorporate on March 3, 1999, is a retailer of urban fashion apparel and accessories for the entire family. The Company offers branded apparel from national brands, as well as private label apparel, accessories and a limited assortment of home decor items. As of February 2, 2013, the Company operated 513 stores in both urban and rural markets in 29 states. The Company�� stores average approximately 10,700 square feet of selling space and are located in neighborhood shopping centers. The Company also offers products under its brands, such as Diva Blue, Red Ape, Vintage Harlem and Lil Ms Hollywood. The Company�� store offers a variety of products for men and women, as well as children. During the fiscal years ended February 2, 2013 (fiscal 2012), the Company opened four new stores.

The Company's merchandise includes apparel, accessories and home decor. Within apparel, the Company offers fashion sportswear for men, women and children, including offerings for newborns, infants, toddlers, boys and girls. Accessories include handbags, jewelry, footwear, belts, intimate apparel and sleepwear. All merchandise sold in the Company's stores is shipped directly from its distribution centers in Darlington, South Carolina and Roland, Oklahoma.

The Company competes with TJX Companies, Inc., Ross Stores, Inc., The Cato Corporation, Burlington Coat Factory Warehouse Corp., Rainbow, Dots, It's Fashion!, Simply Fashions, Wal-Mart and Target, Kmart.

Advisors' Opinion:

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Citi Trends (Nasdaq: CTRN  ) , whose recent revenue and earnings are plotted below.

Best Supermarket Stocks To Watch Right Now: Compass Minerals Intl Inc(CMP)

Compass Minerals International, Inc., through its subsidiaries, produces and markets inorganic mineral products primarily in North America and the United Kingdom. The company operates in two segments, Salt and Specialty Fertilizer. The Salt segment produces salt and magnesium chloride for use in road deicing and dust control, food processing, water softeners, pool salt, and agricultural and industrial applications. This segment also purchases potassium chloride and sells as a finished product. The Specialty Fertilizer segment produces and markets sulphate of potash crop nutrients and industrial grade sulfate of potash for use in the production of specialty fertilizers for vegetables, fruits, potatoes, nuts, tobacco, and turf grass. The company also produces and markets consumer deicing and water conditioning products, ingredients used in consumer and commercial food preparation, and other mineral-based products for consumer, agricultural, and industrial applications. In ad dition, Compass Minerals provides records management services to businesses located in the U.K. The company operates rock salt mines in Goderich, Ontario, Canada; and Winsford, Chesire, the United Kingdom. It primarily serves producers of intermediate chemical products used in the production of vinyls and other chemicals, and pulp and paper, as well as water treatment and other industrial uses. The company markets its products through direct sales personnel, contract personnel, and a network of brokers or manufacturers? representatives. Compass Minerals International, Inc., formerly known as Salt Holdings Corporation, was founded in 1993 and is headquartered in Overland Park, Kansas.

Advisors' Opinion:

• [By Brendan Mathews]

  Compass Minerals (NYSE: CMP  ) is a sleepy producer of a boring product: rock salt. But it has a strong competitive advantage. It owns the world's largest rock salt mine, which luckily is conveniently located near the major deicing markets of the Great Lakes region. This combination of a great mining resource and ideal location provide the company with a wide, crocodile-filled competitive moat.

Best Supermarket Stocks To Watch Right Now: Global X China Materials ETF (CHIM)

Global X China Materials ETF (the Fund) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the S-BOX China Materials Index (the Underlying Index). The Underlying Index is a free float adjusted, liquidity tested and market capitalization-weighted index that is designed to measure performance of the investable universe of companies in the Materials sector of the Chinese economy, as defined by Structured Solutions AG. Global X Management Company, LLC serves as the investment adviser to the Fund. Advisors' Opinion:

• [By pamatlarge]

  Investors looking to short a particular sector can choose from several Global X long ETFs. The Global X China Consumer ETF (CHIQ) concentrates its investments in consumer cyclical goods and consumer defense goods. The Global X China Energy ETF (CHIE) primarily holds stocks in coal, oil and utility companies. The Global X China Financials ETF (CHIX) only invests in financial services companies and real estate companies. The Global X China Industrials ETF (CHII) holds stocks in industrial companies and basic materials companies. The Global X China Materials ETF (CHIM) invests in basic materials stocks. The Global X China Technology ETF (CHIB) holds technology stocks as the core of its investments. All of these ETFs are particularly sensitive to sector downturns and general economic contractions.

Best Supermarket Stocks To Watch Right Now: Emmis Communications Corporation (EMMS)

Emmis Communications Corporation, a diversified media company, engages in radio broadcasting and magazine publishing operations primarily in the United States. It also owns and operates national radio networks in Slovakia and Bulgaria. The company publishes various city and regional magazines, which include Texas Monthly, Los Angeles, Atlanta, Indianapolis Monthly, Cincinnati, Orange Coast, Country Sampler, and related magazines. In addition, it is involved in various businesses, such as Website design and development, digital sales consulting, and operating a news information radio network in Indiana. Further, the company leases its studio and office space. As of April 26, 2012, it owned 18 FM and 2 AM radio stations in New York, Los Angeles, St. Louis, Austin, Indianapolis, and Terre Haute. Emmis Communications Corporation was founded in 1981 and is based in Indianapolis, Indiana.

Advisors' Opinion:

• [By Monica Gerson]

  Emmis Communications (NASDAQ: EMMS) is expected to report its Q2 earnings.

  AngioDynamics (NASDAQ: ANGO) is projected to post its Q1 earnings at $0.03 per share on revenue of $82.54 million.

• [By Laura Brodbeck]

  Thursday

  Earnings Expected From: Lindsay Corporation (NYSE: LNN), Emmis Communications Corporation (NASDAQ: EMMS), API Technologies Corp. (NASDAQ: ATNY) Economic Releases Expected: Australian unemployment rate, Japanese consumer confidence, French industrial output, Italian industrial output, Bank of England interest rate decision, US initial and continuing jobless claims

  Friday

Best Supermarket Stocks To Watch Right Now: Kilroy Realty Corp (KRC)

Kilroy Realty Corporation, incorporated on September 13, 1996, is a self-administered real estate investment trust (REIT). The Company focuses on office and industrial submarkets along the West Coast. The Company owns, develops, acquires and manages real estate assets, consisting primarily of Class A real estate properties in the coastal regions of Los Angeles, Orange County, San Diego County, the San Francisco Bay Area and greater Seattle. As of December 31, 2011, the Company�� portfolio consisted of 104 office buildings (the Office Properties) and 39 industrial buildings (the Industrial Properties). The Company owns its interests in all of its Office Properties and Industrial Properties through the Kilroy Realty, L.P. (the Operating Partnership) and Kilroy Realty Finance Partnership, L.P. (the Finance Partnership). In March 2012, the Company purchased Menlo Corporate Center in Menlo Park, California. In June 2012, the Company purchased two office properties in the Lake Union submarket of Seattle. In January 2013, the Company purchsed Westlake Terry, a two building 320,399 square-foot office property. In September 2013, the Company announced it has completed the purchase of a 13.8 acre Class A office campus in the coastal Del Mar sub-market of San Diego. Effective September 19, 2013, Kilroy Realty Corp acquired The Heights, a owner and operator of an office campus. In January 2014, Kilroy Realty Corp completed the disposition of 13 San Diego office properties in two tranches. In January 2014, Kilroy Realty Corp acquired from The Academy of Motion Pictures Arts and Sciences an approximate four-acre parcel near the intersection of Sunset Boulevard and Vine Street in Hollywood.

On January 28, 2011, the Company acquired one building in 250 Brannan Street, San Francisco, CA. On April 21, 2011, the Company acquired four buildings in 10210, 10220 and 10230 NE Points Drive; 3933 Lake Washington Boulevard NE, Kirkland, WA. On May 12, 2011, the Company acquired one building in 10770 Water! idge Circle, San Diego, CA. On June 3, 2011, the Company acquired one building in 601 108th Avenue N.E., Bellevue, WA. On June 9, 2011, the Company acquired one building in 4040 Civic Center Drive, San Rafael, CA. On September 15, 2011, the Company acquired one building in 201 Third Street, San Francisco, CA. On November 15, 2011, the Company acquired one building in 301 Brannan Street, San Francisco, CA. On December 15, 2011, the Company acquired one building in 370 Third Street, San Francisco, CA. In December 2011, it commenced redevelopment at one of its acquired properties in San Francisco. On January 30, 2012, the Company sold 15004 Innovation Drive, San Diego, CA and 10243 Genetic Center Drive, San Diego, CA. In September 2011, the Company disposed of its interest in 10350 Barnes Canyon and 10120 Pacific Heights Drive, San Diego, CA. In December 2011, the Company disposed of interest in 2031 E. Mariposa Avenue, Los Angeles, CA.

The Company conducts substantially all of its operations through the Operating Partnership of which as of December 31, 2011, it owned a 97.2% general partnership interest. Kilroy Realty Finance, Inc., a wholly owned subsidiary of the Company, is the sole general partner of the Finance Partnership. The Company conducts substantially all of its development activities through Kilroy Services, LLC (KSLLC), which is a wholly owned subsidiary of the Operating Partnership. Its wholly owned subsidiaries include Kilroy Realty TRS, Inc., Kilroy Realty Management, L.P., Kilroy RB, LLC, Kilroy RB II, LLC, Kilroy Realty Northside Drive, LLC and Kilroy Realty 303, LLC. As of December 31, 2011, the Company�� tenants included Intuit, Inc., Bridgepoint Education, Inc., Delta Dental of California, AMN Healthcare, Inc., Hewlett-Packard Company, Fish & Richardson P.C., Scripps Health and Epson America, Inc.

Advisors' Opinion:

• [By Ken McGaha]

  The four REITS I reviewed are Kilroy Realty Corp. (KRC), Kimco Realty Corp. (KIM), Eastgroup Properties (EGP) and Federal Realty Investment Trust (FRT).

• [By Rich Duprey]

  Real estate investment trust�Kilroy Realty� (NYSE: KRC  ) �announced yesterday�its second-quarter dividend of $0.35 per share, the same rate it's paid since 2009.

Best Supermarket Stocks To Watch Right Now: RAIT Financial Trust(RAS)

RAIT Financial Trust operates as a self-managed and self-advised real estate investment trust (REIT). The company, through its subsidiaries, invests in, manages, and services real estate-related assets with a focus on commercial real estate. It also offers a set of debt financing options to the commercial real estate industry along with fixed income trading and advisory services. In addition, RAIT Financial Trust owns and manages a portfolio of commercial real estate properties, and manages real estate-related assets for third parties. The company qualifies as a REIT for federal income tax purposes. As a REIT, it would not be subject to federal income tax to the extent that it distributes at least 90% of its taxable income to its shareholders. RAIT Investment Trust was founded in 1997 and is based in Philadelphia, Pennsylvania.

Advisors' Opinion:

• [By Thomas Sobon]

  Instead of expressing my thoughts in vague generalities, let me be specific and tell you what I am actually doing on a real time basis to cope with the market dynamics occurring right now: I have a core position in one stock, which is the RAIT Financial Trust (RAS). Its size is about 60% of what I would consider to be a "full" position. I also have a lot of cash that I intend to use for trading purposes. Last Friday I sold shares of RAS at $7.55 which I bought on Monday with a low-ball bid of $7.11, so my gain on the trade was 6.2%. In early trading yesterday (Monday July 1) RAS is priced at $7.67, up from where I sold on Friday. That's great news because I accomplished what I wanted to do with the trade and now paper profit on the core shares in my portfolio is increasing.

• [By Marc Bastow]

  Commercial real estate holding real estate investment trust (REIT) RAIT Financial (RAS) raised its quarterly dividend 7% to 16 cents per share, payable on Jan. 31 to share holders of record as of Jan. 7.
  RAS Dividend Yield: 7.48%

• [By Marc Bastow]

  Commercial real-estate loan originator and real estate investment trust RAIT Financial Trust (RAS) raised its quarterly dividend 6% to 17 cents per share, payable April 30 to shareholders of record as of April 4. At more than an 8% yield, RAS stock has the highest yield on this week’s list of dividend stocks.
  RAS Dividend Yield: 8.14%.

• [By Eric Volkman]

  RAIT Financial Trust (NYSE: RAS  ) investors will be getting slightly more than they did last quarter, as a reward for putting their faith in the company (NYSE: RAS  ) . The real estate investment trust has declared a common stock dividend of $0.13 per share, to be handed out on July 31 to shareholders of record as of July 12.�That amount is $0.01, or 8%, higher than RAIT's previous distribution of $0.12, which was paid in April. Prior to that, the firm dispensed $0.10 per share.